UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATIONAND NOTICE OF TERMINATIONOF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934OR

SUSPENSION OF DUTY TO FILE REPORTSUNDER SECTIONS 13 AND 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-41058

VAXXINITY,INC.

(Exact name of registrant as specified in its charter)

505 Odyssey Way

Merritt Island, FL 32953

(254) 244-5739

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executiveoffices)

Class A Common Stock, par value $0.0001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities forwhich

a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon toterminate or

suspend the duty to file reports:

Rule 12g-4(a)(1)

☒

Rule 12g-4(a)(2)

☐

Rule 12h-3(b)(1)(i)

☒

Rule 12h-3(b)(1)(ii)

☐

Rule 15d-6

☐

Rule 15d-22(b)

☐

Approximate number of holders of record as of the certification or notice date: 171

Pursuant to the requirements of the Securities Exchange Act of 1934,as amended, Vaxxinity,Inc. has caused

this certification/notice to be signed on its behalf by the undersigned duly authorizedperson.

Date: May 9, 2024

By:

/s/ Mei Mei Hu

Name:

Mei Mei Hu

Title:

Chief Executive Officer